ArticleJournal of molecular biology2026
Interaction of Bacterial Histidine Phosphatase SixA With Phosphocarrier Protein NPr and Phosphohistidine Analogs.
Article in Journal of molecular biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
SixA is a phosphatase that dephosphorylates phosphohistidine in proteins involved in signaling in bacteria. Using NMR spectroscopy, the interaction of SixA was structurally characterized with one of its functional substrates, the phosphocarrier protein NPr, which shuttles a phosphate group between components of the nitrogen-related phosphotransferase system using a phosphorylated histidine residue. An ensemble structure of the complex was generated combining chemical shift perturbation data and intermolecular paramagnetic relaxation enhancement (PRE) via Gd-DOTA spin-labels attached to NPr, which shows two regions of interaction outside the SixA active site. Simulated molecular crowding did not enhance interaction with these regions. Phosphate, one of the products of the enzyme catalysis, was determined to bind at a site consistent with that seen for a tungstate ion in the SixA X-ray crystallography structure. SixA dephosphorylates NPr too rapidly for NMR characterization of the phosphorylated form; consequently, interaction with substrate analogs was studied, including a mutant of NPr, H16D, to mimic the negative charge of phosphate at the histidine, and non-cleavable analogs of phosphohistidine. The non-cleavable analogs bound in the active site, but at a location distinct from bound phosphate. A phosphohistidine-containing tripeptide was synthesized, and the activity of SixA was measured using liquid chromatography/mass spectrometry. In the presence of phosphate, the activity of SixA was enhanced.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.